Clinical Trials in Salt Lake City

Showing 10241-10260 of 14,325 trials

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01118052

This phase II trial studies the side effects and how well EGEN-001 works in treating patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer that is persistent or has come back. Biological therapies, such as EGEN-001, use substances made from living organisms that may stimulate or suppress the immune system in different ways and stop tumor cells from growing.

Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma

Gynecologic Oncology Group22 participantsStarted Nov 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +8 more locations

COMPLETEDPhase 2< 1 mile

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

NCT01622348

The purpose of this study is to evaluate different dose levels of IMO-3100 compared to placebo administered for 4 weeks to patients with moderate to severe plaque psoriasis.

Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis

Idera Pharmaceuticals, Inc.44 participantsStarted May 2012

Jacksonville, Florida, United States • Alpharetta, Georgia, United States • Macon, Georgia, United States +10 more locations

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Find Trials by Condition in Salt Lake City

FreeStyle Libre Flash Accuracy Study

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Alendronate to Prevent Loss of Bronchoprotection in Asthma

Proof of Concept Study of PEMF (Pulsed Electromagnetic Field) Therapy in Subjects With Osteoarthritis of the Knee

YM443 in Subjects With Functional Dyspepsia

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Abiraterone Post Ketoconazole for Prostate Cancer

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer